SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-126794
Filing Date
2021-10-15
Accepted
2021-10-15 17:03:27
Documents
16
Period of Report
2021-10-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2130098d1_8k.htm   iXBRL 8-K 36476
2 EXHIBIT 4.1 tm2130098d1_ex4-1.htm EX-4.1 104500
3 EXHIBIT 5.1 tm2130098d1_ex5-1.htm EX-5.1 9921
4 EXHIBIT 10.1 tm2130098d1_ex10-1.htm EX-10.1 207469
5 EXHIBIT 99.1 tm2130098d1_ex99-1.htm EX-99.1 9683
  Complete submission text file 0001104659-21-126794.txt   630426

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ptpi-20211013.xsd EX-101.SCH 3201
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptpi-20211013_lab.xml EX-101.LAB 34594
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptpi-20211013_pre.xml EX-101.PRE 22721
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2130098d1_8k_htm.xml XML 3734
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39752 | Film No.: 211326597
SIC: 2834 Pharmaceutical Preparations